SGI Venture Capital
17
7M
17
1.06
1
- Areas of investment
Summary
SGI Venture Capital is the famous VC, which was founded in 2007. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the SGI Venture Capital, startups are often financed by Entrepreneur First, Kakao Ventures. The meaningful sponsors for the fund in investment in the same round are Mega Investment, Entrepreneur First, Charlie Songhurst. In the next rounds fund is usually obtained by Songhyun Investment, Neoplux, MG Investment.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2018.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - South Korea. Among the most successful fund investment fields, there are Artificial Intelligence, Security. Among the most popular portfolio startups of the fund, we may highlight Insignary, Watcha.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 1
- Rounds per year
- 1.06
- Investments by industry
- Medical (5)
- Health Care (3)
- Information Technology (3)
- Software (3)
- Biotechnology (3) Show 37 more
- Investments by region
-
- South Korea (15)
- United States (1)
- Singapore (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.94
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biobab AiBIO | 15 Mar 2021 | Biotechnology, Artificial Intelligence, Medical, Pharmaceutical | Early Stage Venture | 13M | Gangwon-do, South Korea, South Korea |
| PineTree Therapeutics | 07 Jun 2022 | Wellness, Medical, Therapeutics | Early Stage Venture | 23M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.